EH
GSK icon

Equitable Holdings’s GSK GSK Stock Holding History

Equitable Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Buy
66,889
+1,011
+2% +$53.5K 0.02% 561
2026
Q1 		$3.23M Sell
65,878
-3,520
-5% -$191K 0.02% 571
2025
Q4 		$3.4M Sell
69,398
-3,749
-5% -$175K 0.02% 485
2025
Q3 		$3.16M Buy
73,147
+12,868
+21% +$503K 0.02% 473
2025
Q2 		$2.31M Buy
60,279
+8,181
+16% +$313K 0.02% 526
2025
Q1 		$2.02M Buy
52,098
+4,178
+9% +$153K 0.02% 509
2024
Q4 		$1.62M Sell
47,920
-554
-1% -$19.9K 0.02% 534
2024
Q3 		$1.98M Buy
48,474
+4,036
+9% +$165K 0.02% 493
2024
Q2 		$1.71M Buy
44,438
+3,371
+8% +$142K 0.02% 505
2024
Q1 		$1.76M Sell
41,067
-4,158
-9% -$171K 0.02% 480
2023
Q4 		$1.68M Sell
45,225
-92
-0.2% -$3.3K 0.02% 457
2023
Q3 		$1.64M Buy
45,317
+5,026
+12% +$178K 0.02% 420
2023
Q2 		$1.44M Buy
40,291
+4,647
+13% +$167K 0.02% 425
2023
Q1 		$1.27M Buy
35,644
+3,563
+11% +$125K 0.02% 418
2022
Q4 		$1.13M Buy
32,081
+5,379
+20% +$179K 0.02% 419
2022
Q3 		$786K Buy
26,702
+5,167
+24% +$196K 0.02% 448
2022
Q2 		$1.17M Buy
21,535
+334
+2% +$18.4K 0.02% 376
2022
Q1 		$1.15M Buy
21,201
+1,183
+6% +$64.3K 0.02% 380
2021
Q4 		$1.1M Buy
20,018
+2,789
+16% +$145K 0.02% 378
2021
Q3 		$823K Buy
17,229
+131
+0.8% +$6.58K 0.01% 423
2021
Q2 		$851K Buy
17,098
+2,699
+19% +$130K 0.01% 413
2021
Q1 		$642K Buy
14,399
+798
+6% +$36.2K 0.01% 449
2020
Q4 		$626K Buy
13,601
+2,250
+20% +$103K 0.01% 410
2020
Q3 		$534K Sell
11,351
-175
-2% -$8.77K 0.01% 402
2020
Q2 		$588K Buy
11,526
+790
+7% +$40.5K 0.02% 377
2020
Q1 		$508K Buy
10,736
+6,301
+142% +$336K 0.02% 363
2019
Q4 		$261K Buy
+4,435
New +$247K 0.01% 528

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Equitable Holdings's GSK Position: Q2 2026 in Review

Equitable Holdings increased its GSK (GSK) stake by 1.5% in Q2 2026, buying an estimated $53.5K and bringing the position to 66,889 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #561.

Equitable Holdings first reported a position in GSK in Q4 2019 and has held it in 27 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Equitable Holdings held 66,889 shares of GSK worth $3.51M as of Q2 2026.
  • Equitable Holdings bought 1,011 GSK shares in Q2 2026, an estimated $53.5K.
  • GSK made up 0.02% of Equitable Holdings's portfolio in Q2 2026, its #561 holding.
  • Equitable Holdings first reported a position in GSK in Q4 2019 and has held it in 27 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.